We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMC icon
1001
FMC
FMC
$1.42B
$202K ﹤0.01%
+1,618
New +$198K
GRTS
1002
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$195K ﹤0.01%
+56,612
New +$162K
OCGN icon
1003
Ocugen
OCGN
$410M
$193K ﹤0.01%
148,711
+30,481
+26% +$47.5K
CNCE
1004
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$190K ﹤0.01%
32,516
+6,319
+24% +$33.2K
EVER icon
1005
EverQuote
EVER
$886M
$181K ﹤0.01%
12,287
-1,899
-13% -$17.8K
SIGA icon
1006
SIGA Technologies
SIGA
$223M
$175K ﹤0.01%
23,838
+79
+0.3% +$692
ZYXI
1007
DELISTED
Zynex
ZYXI
$165K ﹤0.01%
11,873
-1,836
-13% -$22.2K
ALTO icon
1008
Alto Ingredients
ALTO
$360M
$154K ﹤0.01%
53,352
-8,248
-13% -$29.3K
SIRI icon
1009
SiriusXM
SIRI
$10B
$151K ﹤0.01%
2,594
-401
-13% -$24.7K
SXC icon
1010
SunCoke Energy
SXC
$757M
$147K ﹤0.01%
17,066
-2,638
-13% -$20.4K
AROC icon
1011
Archrock
AROC
$6.33B
$137K ﹤0.01%
15,263
-2,358
-13% -$18.9K
MRNS
1012
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$129K ﹤0.01%
+32,378
New +$159K
AFMD
1013
DELISTED
Affimed
AFMD
$123K ﹤0.01%
9,909
+1,945
+24% +$34.1K
CXW icon
1014
CoreCivic
CXW
$3.1B
$119K ﹤0.01%
10,334
-1,596
-13% -$17.7K
INVE icon
1015
Identive
INVE
$64.6M
$94K ﹤0.01%
12,987
-2,008
-13% -$19.5K
ACCO icon
1016
Acco Brands
ACCO
$369M
$75.7K ﹤0.01%
13,539
-2,094
-13% -$10.9K
GRAB icon
1017
Grab
GRAB
$13.5B
$49.3K ﹤0.01%
15,295
-5,350
-26% -$15.3K
VCSA
1018
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$18.9K ﹤0.01%
+751
New +$35K
SOND
1019
DELISTED
Sonder
SOND
$16K ﹤0.01%
647
-5
-0.8% -$177
ACET icon
1020
Adicet Bio
ACET
$72.8M
-1,368
Closed -$311K
ADC icon
1021
Agree Realty
ADC
$9.68B
-6,978
Closed -$472K
ADAP
1022
DELISTED
Adaptimmune Therapeutics
ADAP
-88,339
Closed -$95K
ADCT icon
1023
ADC Therapeutics
ADCT
$146M
-38,571
Closed -$186K
ALLO icon
1024
Allogene Therapeutics
ALLO
$601M
-78,536
Closed -$848K
AMRN
1025
Amarin Corp
AMRN
$284M
-11,000
Closed -$240K

Similar funds

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.